Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases

Details for Australian Patent Application No. 2005304784 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Jimenez, Juan-Miguel; Aronov, Alex; Li, Pan; Stamos, Dean; Come, Jon R.; Charrier, Jean-Damien; Knegtel, Ronald

Agent Cullens

Pub. Number AU-B-2005304784

PCT Pub. Number WO2006/052913

Priority 60/625,446 04.11.04 US

Filing date 4 November 2005

Wipo publication date 18 May 2006

Acceptance publication date 24 March 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 231/00 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 239/00 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/052913 Priority application(s): WO2006/052913

24 March 2011 Application Accepted

  Published as AU-B-2005304784

21 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005304789-Multi-chamber container and cap therefor

2005304771-Targeted innate immunity